Literature DB >> 1829909

A multicentre study into the reliability of steroid receptor immunocytochemical assay quantification. British Quality Control Group.

R A McClelland1, D Wilson, R Leake, P Finlay, R I Nicholson.   

Abstract

Qualitative and semiquantitative assessments of oestrogen receptor and progesterone receptor positivity determined on previously immunocytochemically stained slides were performed by eight independent assessors. Concordance between assessments of steroid receptor status was good (24/25, 96%). Interassessor variations in estimates of positive immunostaining levels were high, varying by between 10 and 75% for individual slides. In 2 cases estimates for the same section ranged between 15% nuclei positive and 90% nuclei positive. Wide variations were also recorded for slides stained for progesterone receptors. Results using an assessment procedure combining staining intensity and percentage positivity estimates were also subject to marked discordance. A computerised image analysis system, also used to assess slides gave results similar to the mean manually determined percentage positivity values. It is suggested that quality control of steroid receptor immunocytochemical quantification be considered and that automated image analysis may represent an accurate and valid means of achieving this.

Mesh:

Substances:

Year:  1991        PMID: 1829909     DOI: 10.1016/0277-5379(91)90171-9

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  7 in total

1.  Steroid hormone receptors and their clinical significance in cancer.

Authors:  R I Nicholson; R A McClelland; J M Gee
Journal:  J Clin Pathol       Date:  1995-10       Impact factor: 3.411

2.  Immunohistochemistry as an important tool in biomarkers detection and clinical practice.

Authors:  Leandro Luongo de Matos; Damila Cristina Trufelli; Maria Graciela Luongo de Matos; Maria Aparecida da Silva Pinhal
Journal:  Biomark Insights       Date:  2010-02-09

3.  Expression of tissue inhibitor of matrix metalloproteinases (TIMP)-3 protein in invasive breast carcinoma: relation to tumor phenotype and clinical outcome.

Authors:  Eleni Mylona; Christina Magkou; Ioanna Giannopoulou; George Agrogiannis; Sofia Markaki; Antonios Keramopoulos; Lydia Nakopoulou
Journal:  Breast Cancer Res       Date:  2006       Impact factor: 6.466

4.  Dual immunocytochemical analysis of oestrogen and epidermal growth factor receptors in human breast cancer.

Authors:  A K Sharma; K Horgan; A Douglas-Jones; R McClelland; J Gee; R Nicholson
Journal:  Br J Cancer       Date:  1994-06       Impact factor: 7.640

5.  Oestrogen-regulated genes in breast cancer: association of pLIV1 with response to endocrine therapy.

Authors:  R A McClelland; D L Manning; J M Gee; P Willsher; J F Robertson; I O Ellis; R W Blamey; R I Nicholson
Journal:  Br J Cancer       Date:  1998-05       Impact factor: 7.640

6.  Pathological and biological features of mammographically detected invasive breast carcinomas.

Authors:  R Rajakariar; R A Walker
Journal:  Br J Cancer       Date:  1995-01       Impact factor: 7.640

7.  Upregulation of Bcl-2 in nasal polyps from patients with cystic fibrosis.

Authors:  Victor I Scapa; Vijay R Ramakrishnan; Todd T Kingdom
Journal:  Int Forum Allergy Rhinol       Date:  2012-11-07       Impact factor: 3.858

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.